Mura et al., 2013 - Google Patents
Consequences of the 118A> G polymorphism in the OPRM1 gene: translation from bench to bedside?Mura et al., 2013
View PDF- Document ID
- 4713305388265367971
- Author
- Mura E
- Govoni S
- Racchi M
- Carossa V
- Ranzani G
- Allegri M
- van Schaik R
- Publication year
- Publication venue
- Journal of pain research
External Links
Snippet
The 118A> G single nucleotide polymorphism (SNP) in the μ-opioid receptor (OPRM1) gene has been the most described variant in pharmacogenetic studies regarding opioid drugs. Despite evidence for an altered biological function encoded by this variant, this knowledge …
- 102100003212 OPRM1 0 title abstract description 52
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Hybridisation probes
- C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Mura et al. | Consequences of the 118A> G polymorphism in the OPRM1 gene: translation from bench to bedside? | |
J Mistry et al. | Genetics of opioid dependence: a review of the genetic contribution to opioid dependence | |
Zhang et al. | Pharmacogenetic associations of antipsychotic drug-related weight gain: a systematic review and meta-analysis | |
Klepstad et al. | Genetic variability and clinical efficacy of morphine | |
Kolesnikov et al. | Combined catechol-O-methyltransferase and μ-opioid receptor gene polymorphisms affect morphine postoperative analgesia and central side effects | |
Hernandez‐Avila et al. | Association between the cortisol response to opioid blockade and the Asn40Asp polymorphism at the μ‐opioid receptor locus (OPRM1) | |
Heilig et al. | Pharmacogenetic approaches to the treatment of alcohol addiction | |
Lin et al. | Association of functional polymorphisms of the human tryptophan hydroxylase 2 gene with risk for bipolar disorder in Han Chinese | |
Zhang et al. | Association of human μ‐opioid receptor gene polymorphism A118G with fentanyl analgesia consumption in Chinese gynaecological patients | |
Ray et al. | The role of the Asn40Asp polymorphism of the mu opioid receptor gene (OPRM1) on alcoholism etiology and treatment: a critical review | |
Bauer et al. | The role of opioidergic genes in the treatment outcome of drug addiction pharmacotherapy: a systematic review | |
Xu et al. | Identification and characterization of seven new exon 11-associated splice variants of the rat mu opioid receptor gene, OPRM1 | |
Nishizawa et al. | Association between KCNJ6 (GIRK2) gene polymorphism rs2835859 and post-operative analgesia, pain sensitivity, and nicotine dependence | |
Wilkie et al. | A splice site polymorphism in the G-protein β subunit influences antidepressant efficacy in depression | |
KR20160123385A (en) | Methods and compositions for personalized pain management | |
Moran et al. | High genetic addiction risk score (GARS) in chronically prescribed severe chronic opioid probands attending multi-pain clinics: an open clinical pilot trial | |
Hartwell et al. | Pharmacogenetics of alcohol use disorder treatments: an update | |
Al-Eitan et al. | Custom genotyping for substance addiction susceptibility genes in Jordanians of Arab descent | |
Higuchi et al. | New findings on the genetic influences on alcohol use and dependence | |
Seneviratne et al. | Susceptibility locus in neurokinin-1 receptor gene associated with alcohol dependence | |
Kohli et al. | Effects of variation in the human α2A-and α2C-adrenoceptor genes on cognitive tasks and pain perception | |
Cengiz et al. | Orexin/hypocretin receptor, Orx1, gene variants are associated with major depressive disorder | |
Al-Eitan et al. | Mu opioid receptor (OPRM1) as a predictor of treatment outcome in opiate-dependent individuals of Arab descent | |
Li et al. | Analyzing interaction of μ-, δ-and κ-opioid receptor gene variants on alcohol or drug dependence using a pattern discovery-based method | |
Briant et al. | Evidence for association of two variants of the nociceptin/orphanin FQ receptor gene OPRL1 with vulnerability to develop opiate addiction in Caucasians |